His research focused on cell signalling and its role in cancer and the discovery and validation of cancer biomarkers to maximise the chances of prevention, or early detection and good long-term outcomes for people diagnosed with cancer. He had the vision to integrate proteomics with other molecular techniques to characterise gene function, signalling networks and for biomarker discovery and this body of work is his outstanding contribution to cancer research that translates to benefit patients directly.